CYPHER® Sirolimus-eluting
Coronary Stent

The CYPHER® Sirolimus-eluting Coronary Stent is an interventional therapy that has been shown to dramatically improve clinical outcomes. Since the arrival of stents in 1995, in-stent restenosis (a reblockage within the stent) has proven to be the major limitation of interventional cardiology, occurring in approximately 10-40% of patients*. CYPHER® Stents are specifically designed to reduce in-stent restenosis.

CYPHER® Stents are small, spring-like metal stents coated with the drug sirolimus. The drug-eluting stents also include a polymer coating that controls the timed release of the drug inside the vessel.

Since its launch, more than 3,000,000 patients have been treated worldwide with CYPHER® Stents.

For more information please visit CypherStent.com

 

For indications, contraindications, warnings, precautions, and adverse events, please read the Essential Prescribing Information (EPI).

Learn more about our full line of Cardiology products: Download the complete Cardiology Catalog. PDF

To place an order for a Cordis product please visit the
JOHNSON & JOHNSON GATEWAY® Commerce Web site at http://www.commerce.jnjgateway.com.

*Serruys, NEJM, Vol. 344, No. 15, April 2001.